Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors while in the central nervous technique, conolidine modulates alternate molecular targets. A Science Advancements study found that conolidine interacts Along with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid https://helenn198okd2.thelateblog.com/profile